天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2015年
6期
684-689
,共6页
王喆%魏芳%陈海燕%姜埃利
王喆%魏芳%陳海燕%薑埃利
왕철%위방%진해연%강애리
甲状旁腺素%肾透析%血液滤过%Meta分析%终末期肾病
甲狀徬腺素%腎透析%血液濾過%Meta分析%終末期腎病
갑상방선소%신투석%혈액려과%Meta분석%종말기신병
parathyroid hormone%renal dialysis%hemofiltration%Meta-analysis%end-stage renal disease
目的:评价血液灌流和血液透析滤过对维持性血液透析患者甲状旁腺素(PTH)的清除效果,指导临床选择最佳治疗方案。方法计算机检索MEDLINE(1966—2013.8)、Embase(1974—2013.8)、中文万方数据库(1996—2013.8)、CNKI(1979—2013.8)、Cochrane图书馆临床对照试验资料库。手工检索已发表或未发表的相关文献,包括会议摘要等。纳入血液灌流和血液透析滤过对维持性血液透析患者PTH清除作用的随机对照试验。由2名评价员独立对纳入的文献进行质量评价和数据提取,用RevMan 5.2软件进行Meta分析。结果共纳入12项随机对照试验,共计400例患者,Meta分析结果显示血液灌流(HP)与血液透析滤过(HDF)比较,在降低PTH疗效方面差异无统计学意义(WMD=-0.34,95%CI:-12.66~11.98,P=0.96),降低β2微球蛋白(β2-MG)的疗效方面差异无统计学意义(WMD=-2.92,95%CI:-16.64~10.8,P=0.68)。HP对患者皮肤瘙痒的缓解率高于HDF(RR=1.33,95%CI:1.08~1.62,P=0.006)。结论 HP和HDF均可降低终末期肾病维持性血液透析患者PTH的水平,两者疗效无明显差异。
目的:評價血液灌流和血液透析濾過對維持性血液透析患者甲狀徬腺素(PTH)的清除效果,指導臨床選擇最佳治療方案。方法計算機檢索MEDLINE(1966—2013.8)、Embase(1974—2013.8)、中文萬方數據庫(1996—2013.8)、CNKI(1979—2013.8)、Cochrane圖書館臨床對照試驗資料庫。手工檢索已髮錶或未髮錶的相關文獻,包括會議摘要等。納入血液灌流和血液透析濾過對維持性血液透析患者PTH清除作用的隨機對照試驗。由2名評價員獨立對納入的文獻進行質量評價和數據提取,用RevMan 5.2軟件進行Meta分析。結果共納入12項隨機對照試驗,共計400例患者,Meta分析結果顯示血液灌流(HP)與血液透析濾過(HDF)比較,在降低PTH療效方麵差異無統計學意義(WMD=-0.34,95%CI:-12.66~11.98,P=0.96),降低β2微毬蛋白(β2-MG)的療效方麵差異無統計學意義(WMD=-2.92,95%CI:-16.64~10.8,P=0.68)。HP對患者皮膚瘙癢的緩解率高于HDF(RR=1.33,95%CI:1.08~1.62,P=0.006)。結論 HP和HDF均可降低終末期腎病維持性血液透析患者PTH的水平,兩者療效無明顯差異。
목적:평개혈액관류화혈액투석려과대유지성혈액투석환자갑상방선소(PTH)적청제효과,지도림상선택최가치료방안。방법계산궤검색MEDLINE(1966—2013.8)、Embase(1974—2013.8)、중문만방수거고(1996—2013.8)、CNKI(1979—2013.8)、Cochrane도서관림상대조시험자료고。수공검색이발표혹미발표적상관문헌,포괄회의적요등。납입혈액관류화혈액투석려과대유지성혈액투석환자PTH청제작용적수궤대조시험。유2명평개원독립대납입적문헌진행질량평개화수거제취,용RevMan 5.2연건진행Meta분석。결과공납입12항수궤대조시험,공계400례환자,Meta분석결과현시혈액관류(HP)여혈액투석려과(HDF)비교,재강저PTH료효방면차이무통계학의의(WMD=-0.34,95%CI:-12.66~11.98,P=0.96),강저β2미구단백(β2-MG)적료효방면차이무통계학의의(WMD=-2.92,95%CI:-16.64~10.8,P=0.68)。HP대환자피부소양적완해솔고우HDF(RR=1.33,95%CI:1.08~1.62,P=0.006)。결론 HP화HDF균가강저종말기신병유지성혈액투석환자PTH적수평,량자료효무명현차이。
Objective To assess the effect of hemoperfusion (HP) and hemodiafiltration (HDF) on elimination of para?thyroid hormone (PTH) from plasma in long-term hemodialysis patients.Methods MEDLINE (1966—2013.8), Embase (1974—2013.8), Chinese Wanfang database (1996—2013.8),CNKI(1979—2013.8)and the clinical control test database of Cochrane Library were searched. Published reports, unpublished studies and abstract from conference were retrieved manu?ally, all of which include studies of effect of PTH elimination through hemoperfusion and hemodiafiltration. Quality assess?ment and data mining were conducted by two independent investigators who performed meta-analysis using RevMan 5.2. Re?sults A total of 12 reports (400 patients) met the inclusion criteria and were included in this study. The meta-analysis showed that the elimination rate of PTH in long term hemodialysis patients was similar between using hemoperfusion and us?ing hemodiafiltration(WMD=-0.34,95%CI:-12.66-11.98,P=0.96). What’s more the elimination rate ofβ2-MG were also similar(WMD=-2.92,95%CI:-16.64-10.8,P=0.68)between those two treatments. However,The remission rate of pruritus was higher in patients using HP group than in HDF group(RR=1.33,95%CI:1.08-1.62,P=0.006). Conclusion HP and HDF can effectively clear PTH in chronic hemodialysis patients, but there was no statistically different between the two treat?ment methods.